Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Heparin in Severe Sepsis
NCT02135770Phase 3Completed
- Sponsor
- Universitas Indonesia
- Start
- Jan 2013
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in sepsis, septic shock, sponsored by Universitas Indonesia. Started Jan 2013; status: completed.
02
Drugs
heparin
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT02135770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135770.